TFL Viewer Case Study

Built cross-functional team ensuring document readiness and compliance.

Overview

A leading pharmaceutical company conducting a pivotal Phase III trial struggled with inefficiencies in their TFL review process. Disjointed feedback cycles, file overload, and limited version control slowed down approvals, risking submission delays.

The Challenge

A team of 30+ members operated in silos, limiting collaboration and transparency.
Heavy reliance on scattered emails, manual tracking, and misaligned comments.
Redundant document versions led to confusion and prolonged approval timelines.
TFLs managed across hundreds of RTF/PDF files, with no centralized control.
Frequent versioning errors caused uncertainty over the latest approved data.

The Solution

Implemented TFL Viewer to centralize the review process, providing teams a single platform to collaborate efficiently.
Oncology-specific TFL templates drastically streamlined development and review of mock-up shells.
The review and approval process within the tool improved collaboration with vendors/CROs by establishing consistent standards.

The Conclusion

By adopting TFL Viewer, the company eliminated inefficiencies, enhanced collaboration, and ensured data integrity , leading to a smoother, faster clinical trial submission.
Teams worked cohesively, review cycles were drastically reduced, and regulatory compliance was strengthened.
They met their submission timelines ahead of schedule and strengthened internal processes for future clinical trials.

Outcomes

50% reduction in the review cycle with real-time feedback
Enabled seamless collaboration across cross-functional teams, breaking down silos
Streamlined feedback and review processes, enhancing traceability
Established a single source of truth for TFLs, eliminating version confusion
Reduced data discrepancies by 60%, supporting regulatory compliance
Accelerated review timelines, improving overall efficiency

Let's Connect

Tell us what you need , we'll reply within one business day.

We partner with pharma, biotech, CROs, and technology vendors on platform access, outsourcing, and FSP delivery.

Pharma / BiotechCROVendor / Partner